BioSpace News Archive

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into an agreement with the United States Government to support the development, manufacture and initial distribution of an investigational biological therapeutic (CD24Fc, to be named MK-7110) upon approval or Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Merck acquired MK-7110 through the acquisition of OncoImmune,

The Company began enrolling patients in Saturn-1 in September 2020 and expects to initiate its second pivotal registration trial, Saturn-2, in 2021

Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that Dr. Michael Dunne has resigned from his role as Chief Scientific Officer of the Company, effective December 21, 2020.

DermOQ Inc., the oxygen skin care provider of Oxygen Lab™ topical skin care products to physician’s offices, spas, and aestheticians and Element Eight® prestige skin care announced today that it had closed the acquisition of ECHO2 Plus® and Oxyceuticals™ oxygen facial treatment product lines from Skin Products, Inc. for an undisclosed amount.

Study will evaluate the efficacy and safety of NERLYNX® and FASLODEX® in metastatic HR-positive, HER2-negative breast cancer patients selected by the CELsignia® Test

Cardiac arrhythmia relates to irregular rate or rhythm of heartbeat, and while most of these conditions are fairly harmless, certain cases can be utterly serious and even lead to death as the lack of blood flow can severely damage the heart, brain, and other organs.

Acquis Consulting Group ( " Acquis”) announced today that its venture company, SSI Strategy ( " SSI”), a leading Life Sciences consultancy, received a growth investment from Amulet Capital Partners, a middle-market private equity firm focused excl

MOgene, a leading provider of genomics and molecular services worldwide, announced today a new, comprehensive saliva-based COVID-19 testing service to employers for the safety of their employees. When compared to the current collection methods, saliva-based collection devices are easier and less painful to ad

Governor Northam and the Virginia Biotechnology Association announced today that GO Virginia has approved a competitive grant request to help fund Virginia Bio-Connect, a $3.2 million Statewide industry cluster scale up initiative. The project, directed by the Virginia Biotechnology Association, is a multi-regional collaboration designed to increase connectivity and awareness of the existing programs, resources, and commun

At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) wishes to confirm that the Company’s management and Board of Directors are unaware of any material change in the Company’s operations that would account for the recent increase in market activity. About Acasti Acasti is a biopharmaceutical innovator that has historically focused on the research, development and commercialization of prescript